JORIFY Trademark

Trademark Overview

On Monday, July 14, 2008, a trademark application was filed for JORIFY with the United States Patent and Trademark Office. The USPTO has given the JORIFY trademark a serial number of 77521601. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 20, 2012. This trademark is owned by Glaxo Group Limited. The JORIFY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
jorify

General Information

Serial Number77521601
Word MarkJORIFY
Filing DateMonday, July 14, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 20, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 17, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Trademark Events

Event DateEvent Description
Monday, August 20, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 20, 2012ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 17, 2012EXTENSION 5 GRANTED
Monday, January 9, 2012EXTENSION 5 FILED
Monday, January 9, 2012TEAS EXTENSION RECEIVED
Saturday, July 9, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 8, 2011EXTENSION 4 GRANTED
Tuesday, July 5, 2011EXTENSION 4 FILED
Tuesday, July 5, 2011TEAS EXTENSION RECEIVED
Tuesday, December 21, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 20, 2010EXTENSION 3 GRANTED
Friday, December 3, 2010EXTENSION 3 FILED
Friday, December 3, 2010TEAS EXTENSION RECEIVED
Tuesday, August 10, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, August 8, 2010EXTENSION 2 GRANTED
Wednesday, July 7, 2010EXTENSION 2 FILED
Sunday, August 8, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 7, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 11, 2009EXTENSION 1 GRANTED
Friday, December 11, 2009EXTENSION 1 FILED
Friday, December 11, 2009TEAS EXTENSION RECEIVED
Monday, October 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 21, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 28, 2009PUBLISHED FOR OPPOSITION
Wednesday, April 8, 2009NOTICE OF PUBLICATION
Tuesday, March 24, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 23, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 20, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 20, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 20, 2009ASSIGNED TO LIE
Thursday, March 12, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 11, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 11, 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, March 5, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 5, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 27, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, October 27, 2008LETTER OF SUSPENSION E-MAILED
Monday, October 27, 2008SUSPENSION LETTER WRITTEN
Tuesday, October 21, 2008ASSIGNED TO EXAMINER
Thursday, July 17, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

jorify pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic